Related Experiment Videos
Issues in the measurement of nausea
A Del Favero1, M Tonato, F Roila
1Istituto Clinica Medica 1, Universita di Perugia, Italy.
The British Journal of Cancer. Supplement
|December 1, 1992
Summary
Assessing nausea with discrete scales is as effective as using analogue scales for antiemetic trials. Evaluating quantity, duration, and intensity of nausea improves sensitivity in measuring treatment effects.
Area of Science:
- Oncology
- Clinical Pharmacology
- Patient-Reported Outcomes
Background:
- Accurate measurement of nausea is critical for assessing antiemetic drug efficacy.
- Standardized assessment of nausea frequency, duration, and intensity is required in clinical trials.
- Various scales exist for nausea measurement, but their comparative effectiveness is not fully established.
Purpose of the Study:
- To evaluate and compare different methods for measuring nausea in cancer patients undergoing chemotherapy.
- To determine the most sensitive approach for detecting differences in nausea experienced by patients.
Main Methods:
- Compared three nausea measurement scales: discrete scale (DS), visual analogue scale (VAS), and continuous chromatic analogue scale (ACCS).
- Assessed four dimensions of nausea: maximal intensity (MI), entity (E), duration (D), and quantity (Q).
- Evaluated data from 849 cancer patients receiving chemotherapy.
Main Results:
- A substantial agreement was found between the different nausea measurement scales.
- No significant advantage of analogue scales (VAS, ACCS) over the discrete scale (DS) was observed.
- Sensitivity in detecting differences increased as broader aspects of nausea were assessed (Q > E > MI).
Conclusions:
- Discrete scales are a viable and effective method for measuring nausea in antiemetic clinical trials.
- Assessing the quantity of nausea appears to be more sensitive than evaluating intensity or entity alone.
- Comprehensive assessment of nausea dimensions enhances the evaluation of antiemetic treatment efficacy.